A compound that blocks a key inflammatory pathway in the brain reverses cognitive decline in mice.
“Then they gave the mice a drug that inhibited the action of the TGF-ß receptor, impairing TGF-ß signaling and reversing the accompanying cognitive dysfunction. These findings suggest that reducing inflammation in the brain could serve as a means to restore cognitive function in older adults.”